Diese Übersicht listet die im Register clinicaltrials.gov registrierten klinischen ophthalmologischen Studien. Sollten Sie eine Studie vermissen, senden Sie bitte die zugehörige NCT-Nummer an geschaeftsstelle@dog.org.

Study of Metastatic Ocular Melanoma »Details
Comparison of Ectoin® Containing Eye Drops and Ectoin® Containing Eye Spray With the Eye Spray Tears Again® »Details
Equivalence Study of Dorzolamide 2% Eye Drops Solution »Details
Spectral Domain OCT Imaging in Patients With Optic Nerve Head Drusen (Tuebingen SD-OCT IN OPTIC NERVE HEAD DRUSEN STUDY) »Details
Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension »Details
Assessment of Visual Field-related Endpoints in Patients With Non-arteritic Ischemic Optic Neuropathy »Details
A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting »Details
A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) »Details
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons »Details
Trial of Alternating Current Stimulation in Optic Neuropathy »Details
Central Corneal Thickness With SENSIMED Triggerfish »Details
Visual Reconstitution Therapy After Optic Neuritis »Details
Testing of Innocuousness of Benzalkonium Chloride on the Eye Concerning Possible Growth of Langerhans Cells »Details
Safety and Efficacy of NovaTears® + Omega-3 (0.2%) Eye Drops on Signs and Symptoms of Dry Eye »Details
NovaTears® Eye Drops Observational Study NT-003 »Details
Selective Lasertrabeculoplasty and Ocular Hemodynamics in Glaucoma »Details
An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease »Details
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms »Details
Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability »Details
Comparing Eye Pressure Using Maximal Tolerated Local Therapy or Systemic Acetazolamide »Details
Usability of the Software MacuFix for the Categorization of Metamorphopsia »Details
Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation »Details
The Effect of Selective Laser Trabeculoplasty (SLT) on Ocular Rigidity »Details
NovaTears® Eye Drops Observational Study »Details
Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis »Details
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension »Details
Training of Eye Movements in Glaucoma »Details
External Lid Loading for the Temporary Treatment of the Paresis of the M. Orbicularis Oculi: a Clinical Note »Details
Treatment of Patients With Optic Nerve Damage Patients Using Electrostimulation »Details
A Study of the Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED) »Details
Early Diagnosis, Pathogenesis and Progression of Open Angle Glaucoma »Details
Computer-aided Diagnosis of Ocular Diseases Based on Corneal Biomechanics »Details
Changes of the Peripapillary Retinal Nerve Fiber Layer After Filtration Surgery in Glaucoma Patients »Details
Safety Study of a Sutureless Amniotic Membran Transplantation to Treat Ocular Surface Disorders (Expanded Access) »Details
Comparison of Sensimed Triggerfish (TF) 24 Hour Monitoring of the Eye in Glaucoma Patients Before and After Trabeculectomy »Details
Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients »Details
Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB) »Details
Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials »Details
Intermediate Vision in a Driving Simulator Environment: Comparison of the J&J EYHANCE With a Conventional Monofoc. IOL »Details
A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers »Details
Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea »Details
Paraorbital-Occipital Electric Stimulation in Patients With Optic Neuropathy (BCT_optnerve) »Details
A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. »Details
Influence of Acupuncture to Ocular Microcirculation in Patients With Diabetes Mellitus »Details
A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin »Details
Non-invasive Assessment of Intraocular Pressure in MPS by Use of the Ocular Response Analyzer. »Details
Corneal Changes After Crosslinking in Keratoconus Patients Compared to the Untreated Fellow Eye »Details
Comparison of Non-mydriatic Camera Systems in a Female Health Hospital »Details
Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab »Details
MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study) »Details
Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy »Details
Paraorbital-Occipital Alternating Current Stimulation Therapy for Optic Neuropathy (MCT_optnerve) »Details
Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion »Details
RHODOS Follow-up Single-visit Study »Details
G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate-randomized Tandem Study With Different Endoscopist »Details
Comparing Detection of Standard Colonoscopy, CAD-EYE and Combined CAD-EYE and G-EYE® Aided Colonoscopy »Details
PMCF Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS »Details
Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy »Details
Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice »Details
LLETZ Under Direct Colposcopic Vision »Details
Study of Eye Movement Desensitization and Reprocessing (EMDR) Working Mechanism »Details
Visual Perception After Virtual Implantation »Details
Intraocular Position of Secondary Iris-Fixated IOLs in Aphakic Eyes »Details
Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain »Details
Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) in Dental Phobia »Details
Endocuff Vision Assisted vs. Standard Polyp Resection in the Colorectum »Details
Vision Assessment With the Quick Contrast Sensitivity Function (qCSF) Method in Healthy Controls and MS »Details
Effects of Ketamine on Eye Movements, Perception and Brain Function »Details
Non-invasive Current Stimulation for Restoration of Vision »Details
Clinical Value of G-EYE Colonoscopy in Daily Practice for Adenoma Detection and Time for Polyp Removal »Details
A Dual Tandem Study - SC vs. CAD-EYE vs. CAD-EYE With G-EYE »Details
Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre »Details
DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) »Details
Comparsion of King Vision® Standard Blade and King Vision® Channeled Blade in Patients Scheduled for Tracheal Intubation »Details
Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis »Details
Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of AMD-patients »Details
Establishment of an Anaesthetic Protocol for Examinations for Children With Glaucoma or Suspected Glaucoma »Details
The HEP-OKS Study - Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients »Details
Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution »Details
Observation of Treatment Patterns With Lucentis in Approved Indications »Details
Trabeculectomy Versus Canaloplasty to Treat Glaucoma »Details
COSOPT-S® Treatment Versus Acetazolamide Before Trabeculectomy »Details
Comparison of Visual Fields: Humphrey Field Analyzer (HFA) SITA Strategy, SCOPE (GATE Strategy) and Humphrey MATRIX Perimeter »Details
Indomethacin Eyedrops Compared With Ketorolac Eyedrops for Ocular Inflammation Following Cataract Surgery »Details
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension »Details
Evaluation of a Night Spectacle Correction Concerning an Improvement of Mesopic Vision Quality »Details
Hypnosis for Eye Surgery »Details
Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye »Details
Visual Acuity After the Combined Binocular Implantation of +2.75 Diopters and +3.25 Diopters Tecnis Multifocal Intraocular Lenses. »Details
Visual Acuity After the Combined Binocular Implantation of +2.5 Diopters and +3.0 Diopters ReSTOR Multifocal Intraocular Lenses. »Details
Visual Acuity After the Combined Binocular Implantation of +2.0 Diopters and +3.0 Diopters Oculentis Multifocal Intraocular Lenses. »Details
Combined tDCS and Vision Restoration Training in Subacute Stroke Rehabilitation: A Pilot Study »Details
Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study »Details
Argus II Retinal Prosthesis System - Better Vision RP Study »Details
Aflibercept Injection Into the Vitreous Body of the Eye: Study to Learn More About Patient Relevant Outcomes, Real World Treatment Patterns and How Well the Treatment Works for Patients Suffering From Abnormal Growth of New Blood Vessels Under the Retina. »Details
CyclASol® Phase 1 Study »Details
Sparing of the Fovea in Geographic Atrophy Progression »Details
Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia »Details
Eye Screening in German Secondary Diabetes Care Centers »Details
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension »Details
A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients »Details
Functional Neuroimaging of Cortical Plasticity in the Human Visual System »Details
Effect of Protanopia on the Brightness Perception of Brake Lights »Details
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension »Details
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers »Details
Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Delivery Device in Subjects With Preoperative Corneal Astigmatism »Details
Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial »Details
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension »Details
Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension »Details
A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension »Details
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma »Details
Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma »Details
Comparison of WaveLight Analyzer and Alcon LadarWave »Details
BIIB033 In Acute Optic Neuritis (AON) »Details
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye »Details
Safety and Efficacy of a Trifocal Intraocular Lens (IOL) POD L GF in Comparison With a Multifocal and a Monofocal IOL »Details
NovaTears® Eye Drops Observational Study NT-002 »Details
Comparison of Adenoma Detection Rate With ENDOCUFF VISION® vs. G-EYE® »Details
HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED) »Details
Comparison of INVOS and FORE SIGHT Cerebral Oximeter »Details
Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome »Details
Cervical Kinematics' Reliability: Zero Positioning Using a 3-D-bulls Eye Spirit Level »Details
Atacicept in Subjects With Optic Neuritis »Details
Combined Triple Therapy in Diabetic Retinopathy (DRP) »Details
Clinical Performance of Two Daily Disposable Contact Lenses - Study 1 »Details
Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG) »Details
SYL040012, Treatment for Open Angle Glaucoma »Details
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) »Details
Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON) »Details
Prostatectomies Using Einstein Vision® 3D »Details
Reduction of Intraoperative EEG Burst Suppression »Details
Development of an ICU Risk Score »Details
A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra »Details
5 Years Long Term Results After Standalone CyPass-Implantation »Details
A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma »Details
THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease »Details
Biomechanical Changes After Trabeculectomy »Details
Safety and Performance Study of the CyPass System Applier Model 241 »Details
Long Term Outcome After Ahmed Glaucoma Valve »Details
Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence Tomography »Details
Comparison of Sensimed Triggerfish With Goldmann Applanation Tonometry and Perkins Tonometry »Details
Assessment of Advanced Glaucomatous Visual Field Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL) »Details
Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma »Details
Safety and Efficacy of Changing to DuoTrav From Prior Therapy »Details
Trabeculectomy Versus Canaloplasty »Details
Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany »Details
The Influence of Anterior Chamber Fluid Mediators on the Success Rate of Trabeculectomy »Details
Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy »Details
SENSIMED Triggerfish Discomfort During IOP Monitoring »Details
Contrast Sensitivity in Glaucoma »Details
Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery »Details
Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav »Details
Multidrug Resistance After Trabeculectomy With Mitomycin C »Details
Long-Term Non-Interventional Latanoprost Study »Details
Post Authorisation Safety Study With Raxone in LHON Patients »Details
Comparison of Colonoscopy Adenoma Detection Yield »Details
Comparison of Videolaryngoscopy and Direct Laryngoscopy in Pediatric Airway Management »Details
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR »Details
Non-invasive Optical Detection of Iron Deficiency »Details
Investigation of Chronic Inflammatory Processes in Male Individuals With Hypohidrotic Ectodermal Dysplasia »Details
Non-comparative Trial Following Participants Implanted Bilaterally With Mini WELL Toric Ready Intraocular Lens for 6 Months After the Second Eye Implant (FUSION) »Details
A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION »Details
Early Evaluation of the Beacon Aqueous Microshunt in Patients Refractory to Drug Therapy in the European Union »Details
Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice »Details
A Comparison of Video Laryngoscopes and the Direct Laryngoscope in Simulated Normal and Difficult Infant Airway. »Details
Performance Evaluation of the NaviAid™ G-Eye System »Details
Non-invasive Optical Detection of Iron Deficiency in Children »Details
Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study »Details
Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study »Details
Dresden Glaucoma and Treatment Study (DGTS) »Details
Long-Term Assessment of Remyelinating Therapy »Details
Study of OMNI Surgical System and iStent for Eyes With OAG (Trident) »Details
Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy »Details
Comparison of a Smartphone Based Self Refraction Tool With Conventional Refraction Error Estimation Methods »Details
Measurement of Refractive SE Following Implantation of LS313 MF30 IOL »Details
Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Roflufocon D »Details
Tear Film Stability of DAILIES® AquaComfort Plus® Contact Lenses vs. MyDay® Daily Disposable Contact Lenses »Details
Effect of Brimonidine on Corneal Thickness »Details
Canthaxanthin Retinopathy: A Long-term Observation »Details
Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema »Details
Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice »Details
Functional Antigen Matching in Corneal Transplantation »Details
Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures »Details
Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration »Details
Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension »Details
Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients »Details
Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy »Details
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension »Details
Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Hexafocon A »Details
Biomarker for Patients With Fabry Disease (BioFabry) »Details
One-month Clinical Evaluation of Silicone Hydrogel Definitive 65 HPT Contact Lenses »Details
Three-month Clinical Evaluation of Silicone Hydrogel Definitive 65 Contact Lenses »Details
A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle Glaucoma »Details
Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension »Details
24h Continuous Intraocular Pressure (IOP) Monitoring vs Goldmann Applanation Tonometry »Details
RESCUE and REVERSE Long-term Follow-up »Details
Intravitreal Aflibercept Injection in Vision Impairment Due to DME »Details
Out-of-Hospital Randomized Comparison of Video-assisted Endotracheal Intubation »Details
Intervention Trial in Early Age-related Macular Degeneration »Details
Evaluation of a Spherical Hydrophilic Acrylic Intraocular Lens »Details
Efficacy and Tolerability of Blephademodex Wipes »Details
REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients »Details
Evaluation of a Trifocal Lens »Details
Z8 OCT-controlled 2D vs 3D LASIK »Details
VISPER: Randomised Comparison of Two OVDs in Cataract Surgery »Details
Compare Visual Outcomes Using a New Diagnostic Device »Details
Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration »Details
The Homburg Keratoconus Center (HKC) »Details
Laser In-situ Keratomileusis With Crosslinking Compared to Conventional LASIK in Patients With High Myopia »Details
Low-dose AtropIne for Myopia Control in Children »Details
To Compare Early Rotation of Two Extended Depth of Focus Intraocular Lenses »Details
Visual Outcomes After Presbyopic Lens Exchange »Details
Posterior Capsule Opacification Following Cataract Surgery With Implantation of the MICS IOL L313 »Details
EDoF IOLs vs Monofocal IOL »Details
Clinical Safety and Efficacy of CT ASPHINA 509 Lenses »Details
Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy »Details
A Single Centre Study to Analyze Cataract Surgery Following Femtosecond Laser-Assisted and Manual Cataract Surgery »Details
Comparison of Lipiflow®-Treatment and a Standard Lid Hygiene Regime »Details
A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine »Details
Evaluation of Visual Acuity and Patient Satisfaction With AT LISA TRI 839MP Intraocular Lenses »Details
Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD »Details
Clinical Comparison of Two Daily Disposable Lenses Among Daily Disposable Lens Wearers »Details
Blephacura Versus Baby Shampoo to Treat Blepharitis »Details
Brilliant Blue Versus Indocyanine Green »Details
Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis »Details
Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Retinopathy »Details
Night Driving Pilot »Details
Check of Optical Features and Accuracy of the Zeiss ZO Lens After Selection and Calculation With OKULIX »Details
Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens »Details
Influencing Factors in Uveitis »Details
Open Label Safety Study of a Birch Pollen Allergen Extract »Details
Evaluation of the Safety and Effectiveness of the Akreos MI Five-0 Intraocular Lens. »Details
Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A »Details
Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC) »Details
Study to Assess the Efficacy and Safety of Raxone in LHON Patients »Details
Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma »Details
Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus »Details
Intraocular Pressure (IOP) Assessed by Dynamic Contour Tonometer (DCT) and Goldman Applanation Tonometry (GAT) »Details
Multicenter Trial of Immunotherapy With House Dust Mite Allergoid »Details
Blepharospasm Short Interval »Details
Indocyanine Green or Trypan Blue for Delamination of the Internal Limiting Membrane in Macular Hole Surgery »Details
Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis »Details
Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) »Details
MINIject Glaucoma Implant in European Patients »Details
Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG) »Details
A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease »Details
Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME. »Details
Intrastromal Correction of Ametropia by a Femtosecond Laser »Details
Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing. »Details
Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC) »Details
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) »Details
EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye »Details
Ophthalmologic Examinations After Infusion of ZK200775 »Details
Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and Adolescents »Details
German Corneal Cross Linking Register »Details
A Prospective Randomized Comparison of the Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®) »Details
A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis »Details
Development, Intraoperative Demonstration and Visualization of Surgical Assistance Functions »Details
Hamburg City Health Study - a German Cohort Study »Details
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) »Details
An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD »Details
To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema »Details
Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation »Details
Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE) »Details
A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients. »Details
Prospective Trial to Compare the Clinical Efficiency of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy »Details
Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease »Details
Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction »Details
A Multi Focal Visual Outcome Study Using Different Near Additions »Details
Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. »Details
Clinical Evaluation of an Investigational Soft Contact Lens »Details
TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease »Details
Screening for Advanced Heart Failure Treatment (SEE-HF) »Details
Dresden Corneal Disease and Treatment Study »Details
Rotational Stability Analysis of a Toric Monofocal IOL »Details
Clinical Results of Small Incision Lenticule Extraction (SMILE) for the Correction of High Myopia »Details
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm »Details
Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens »Details
Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation »Details
A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe »Details
Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen »Details
An Integrated Analysis of the Effectiveness of Intravitreal (IVT) Aflibercept (Eylea) in Routine Clinical Practice Based on Two Large Observational Studies »Details
A Study to Address Precision and Refractive Predictability of Femtosecond Laser-assisted Astigmatic Keratotomy Following the Cataract Surgery »Details
Aflibercept in Patients With Pigment Epithelial Detachments (PED) »Details
Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration »Details
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) »Details
Long-term Safety and Performance of the ARGOS-SC Suprachoroidal Pressure Sensor System in Patients With Glaucoma Underwent Non-penetrating Glaucoma Surgery »Details
Observational Study - ILM Peeling »Details
Reticular Pseudodrusen Progression Study »Details
Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT) »Details
Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration »Details
Performance and Safety of the ARGOS-SC01 Suprachoroidal Pressure Sensor in Patients With Glaucoma Undergoing Non-penetrating Glaucoma Surgery »Details
Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration. »Details
Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis) »Details
Acrylate Intraocular Lenses in Cataract Surgery of Uveitis Patients »Details
Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green. »Details
Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in Germany »Details
Effects of Xanthophylls on Optical Density »Details
Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD »Details
Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD »Details
Combined Therapy in Age-Related Macular Degeneration (ARMD) »Details
Subretinal Macugen® for Neovascular Age-Related Macular Degeneration »Details
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA) »Details
Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial »Details
Assessment of Psychological Strain and Perioperative Fear in Intravitreal Injections »Details
Selective RPE Laser Treatment (SRT) for Various Macular Diseases »Details
Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration »Details
Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG »Details
Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON) »Details
Rate of Progression in EYS Related Retinal Degeneration »Details
Study Assessing Double-masked Uveitis Treatment »Details
Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments »Details
Drinking Habits of Glaucoma Patients and Age Matched Controls »Details
Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye »Details
A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD) »Details
Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis »Details
Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration »Details
12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD) »Details
ASCEND GO-2: Study of RVT-1401 for the Treatment of Patients With Active, Moderate to Severe Graves' Ophthalmopathy ( GO ) »Details
Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL) »Details
Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution »Details
Long Term Observation of Patient Satisfaction Post INTRACOR Treatment Based on Patient Perception and Diagnostic Data »Details
Intrastromal Presbyopia Correction by Means of a Femtosecond Laser »Details
A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension. »Details
A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis »Details
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert »Details
AMD Phenotype and Genotype Study »Details
UNITE Study: Understanding New Interventions With GBM ThErapy »Details
Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis »Details
Drug Eluting Stents In The Critically Ischemic Lower Leg »Details
Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG) »Details
Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study »Details
Effect of Ruboxistaurin on Clinically Significant Macular Edema »Details
Clinical Evaluation of Visco-Assisted CyPass® Micro-Stent Implantation in Patients With Open Angle Glaucoma »Details
VEGF In Systemic Circulation Of ROP-infants »Details
Anti-VEGF Therapy Versus Dexamethasone Implant for DME »Details
Directional Spread in Geographic Atrophy »Details
Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema »Details
Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients »Details
Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab »Details
Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers »Details
Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease »Details
Observational Study to Assess the Effect of Iluvien® in DME Patients Insufficiently Responsive to Available Therapies »Details
Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecond Laser System »Details
Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema »Details
Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome »Details
A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO) »Details
Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial) »Details
A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration »Details
A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis »Details
Biomarker for Maroteaux-Lamy Disease (BioMaroteaux) »Details
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks »Details
Ultrastructural Changes of Trabeculectomy Specimens in Patients With Uveitic Secondary Glaucoma »Details
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease »Details
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes »Details
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects »Details
Characterization of Pseudoxanthoma Elasticum »Details
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene. »Details
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3) »Details
A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) »Details
Comparison of Corneal Grafts Cultured in Serum-free Versus Corneal Grafts Cultured in Serum Supplemented Culture Media »Details
CyPass Clinical Experience Study »Details
Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis »Details
STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program »Details
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Europe (PHY2104) »Details
Premium Trifocal IOL Comparative Analysis »Details
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo »Details
Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F »Details
INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD »Details
Satisfaction With XEN Gel Stent Versus Trabeculectomy for the Treatment of Glaucoma »Details
A Study of the Glaukos Trabecular Micro-bypass Stent in Open Angle Glaucoma Subjects 1 Stent Versus 2 »Details
Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants »Details
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer »Details
Safety and Performance Study of the ARGOS-IO System in Patients Undergoing Boston Keratoprosthesis Implantation »Details
Acceptance and Efficacy of Live Supervision »Details
PMCF Study on SMILE Treatment of Myopia With and Without Astigmatism »Details
Cataract Online Refraction Evaluation: A Multi Center Randomized Controlled Trial »Details
A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects »Details
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK) »Details
Blepharospasm Tools »Details
PDE6A Gene Therapy for Retinitis Pigmentosa »Details
The Postoperative Head Position as a Predictor of the Surgical Outcome After DMEK »Details
LENS - Long-term Eltrombopag Observational Study »Details
THOR - Tübingen Choroideremia Gene Therapy Trial »Details
Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet) »Details
STARflo European Safety and Efficacy Study »Details
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01) »Details
Assessment of Homonymous Visual Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL) »Details
Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial »Details
Test-retest Study With [18F]PI-2620 in PSP-RS and NDC »Details
Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) »Details
RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY »Details
Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity »Details
Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa »Details
Natural History in CCFDN and IBM Syndromes »Details
A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma. »Details
Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis »Details
Six Month lead-in Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%) »Details
Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy »Details
Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy »Details
A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy »Details
Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy »Details
Autofluorescence in Uveitic and Diabetic Macular Edema »Details
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE) »Details
Microperimetry in Macular Edema »Details
High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP »Details
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema »Details
Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion »Details
Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion »Details
A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema »Details
Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk »Details
A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects. »Details
Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors »Details
Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging »Details
Investigation of Biomarkers in Susac Syndrome »Details
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) »Details
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT »Details
Natural History Study of CEP290-Related Retinal Degeneration »Details
A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD »Details
Restoration vs. Compensation in Neurovisual Rehabilitation of Visual Field Defects »Details
Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis »Details
BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome »Details
Multiparametric Characterization of Orbital Tumors by MRI »Details
Safety and Efficacy of AIN457 in Noninfectious Uveitis »Details
Paraorbital-Occipital Alternating Current Stimulation Therapy of Patients With Post-Chiasmatic Lesions »Details
PD of VAY736 in Patients With Primary Sjögren's Syndrome »Details
Low Dose Cyclosporin A in Primary Sjögren Syndrome »Details
Clinical Assessment of a HYDRAGLYDE® Regimen »Details
Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery. »Details
ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy »Details
MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation »Details
Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome »Details
Perception of Children With Visible Untreated and Treated Caries »Details
Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis »Details
Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy »Details
Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis »Details
Long Term Vital Parameter Monitoring (LAVIMO) »Details
Evaluation of the Efficacy of a Two-week EMST on Dysphagia in Parkinsonian Patients »Details
Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch »Details
A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration. »Details
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) »Details
Clinical Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) »Details
PMCF Study on EDOF (Isopure) vs Monofocal (Micropure) IOL »Details
Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) »Details
A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis »Details
Vitamin D and Grass Pollen Specific Immunotherapy »Details
Phase II HDM-SPIRE Safety and Efficacy Study »Details
Phase III Cat-PAD Study »Details
A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis »Details
GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) »Details
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis »Details
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment »Details
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis »Details
Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD »Details
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 »Details
EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 »Details
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis »Details
Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration »Details
Bilateral Recession or Unilateral Recession-Resection as Surgery for Infantile Esotropia »Details
Alprostadil in Maculopathy Study (AIMS) »Details
Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome »Details
Electronic Recording of Compliance With Occlusion Therapy for Amblyopia »Details
Use of the VisuMax Femtosecond Laser Lenticule Removal Procedure for the Correction of Hyperopia »Details
Post-Market Clinical Investigation of the Clareon® IOL »Details
Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis »Details
A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma »Details
Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT »Details
Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE) »Details
Influence of Systemic Parameters in Diabetic Macular Edema - LIPSIA Study »Details
Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema »Details
Tyrosine Allergoid Paediatric and Adult Study »Details
Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels »Details
Dexamethasone-implant for the Treatment of RVO »Details
A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO) »Details
Quality of Life in Patients With Intermediate Uveitis »Details
Retrospective NIS to Evaluate the Patient Benefit of TES »Details
Impact of Acute Cerebral Diseases on the Autonomous Nervous System: Progression and Correlation to Therapy and Outcome »Details
TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy »Details
Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis »Details
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema »Details
2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma »Details
German Spondyloarthritis Inception Cohort »Details
Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE) »Details
Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema »Details
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts »Details
Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients »Details
Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia »Details
Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation »Details
A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study »Details
Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis »Details
Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept »Details
Effectiveness of Periocular Drug Injection in CATaract Surgery »Details
Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications »Details
Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration »Details
Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON) »Details
Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment. »Details
A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration »Details
A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections »Details
Fundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy »Details
Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration »Details
Development of Novel Clinical Endpoints in Intermediate AMD »Details
Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration »Details
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration »Details
A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD] »Details
Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1) »Details
OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD) »Details
A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD) »Details
Depigoid Birch 5000 Longterm Study in Adults and Adolescents »Details
Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma »Details
Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration »Details
Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD) »Details
A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration »Details
New Strategies to Detect Cancers in Carriers of Mutations in RB1 »Details
Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD »Details
A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy »Details
A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy »Details
Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration »Details
A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome) »Details
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE) »Details
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II) »Details
Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. »Details
Social Interaction and Compassion in Depression »Details
Cognitive Reappraisal in Adolescents With Major Depression »Details
Ameliorating Cognitive Control in Binge Eating Disorder »Details
An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study »Details
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA) »Details
Evaluation of Long-Term Clinical Acceptability and Satisfaction With the IC-8 Intraocular Lens »Details
Study to Evaluate the Safety of the EndoArt™ for Treatment of Subjects Suffering From Corneal Edema »Details
A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration »Details
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma »Details
EndoArt® Implantation in Subjects With Chronic Corneal Edema »Details
Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X) »Details
Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy »Details
OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD) »Details
Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis »Details
38 Week Extension Study to CAIN457C2303 »Details
Safety and Effectiveness Study of the AcuFocus Corneal Inlay ACI 7000PDT in Presbyopes »Details
Phenotypes, Biomarkers and Pathophysiology in Spastic Ataxias »Details
Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis »Details
Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis »Details
Clinical Trial With PRECIZON Presbyopic »Details
Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit »Details
The KHENEREXT Study »Details
Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO »Details
An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa »Details
Therapeutic Potential of Omega-3 Fatty Acids Supplementation in Dry Macular Degeneration and Stargardt Disease »Details
An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD »Details
A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) »Details
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients »Details
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy »Details
Argus® II Retinal Prosthesis System Post-Market Surveillance Study »Details
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) »Details
A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration »Details
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration »Details
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) »Details
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema »Details
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration »Details
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration »Details
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema »Details
Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema »Details
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) »Details
Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema »Details
Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME) »Details
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study) »Details
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema »Details
Research of Biomarkers in Parkinson Disease »Details
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration »Details
Povidone-iodine Antisepsis for Strabismus Surgery »Details
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration »Details
Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema »Details
Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) »Details
Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears »Details
Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis) »Details
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) »Details
Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy »Details
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease »Details
EyeConic: Qualification for Cone-Optogenetics »Details
Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA) »Details
Aflibercept in Polypoidal Choroidal Vasculopathy »Details
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD) »Details
Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects Lesion(s) in Adolescent Subjects With STGD1 »Details
A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Participants With Diabetic Macular Edema Treated With Faricimab »Details
Myfortic for the Treatment of Non-infectious Intermediate Uveitis »Details
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration »Details
Safety and Efficacy of Emixustat in Stargardt Disease »Details
ADenoVirus Initiative Study in Epidemiology in Germany »Details
Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery »Details
Effect of Choline Fenofibrate (SLV348) on Macular Edema »Details
CNGB1 and Allied Disorders »Details
A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma »Details
Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat Tauopathies »Details
Transcorneal Electrical Stimulation - Multicenter Safety Study »Details
A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy »Details
A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP) »Details
Study of BIIB092 in Participants With Progressive Supranuclear Palsy »Details
Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy »Details
A Randomised, Double-blind, Placebo Controlled Study With Oralgen Grass Pollen Rhinoconjunctivitis »Details
A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP) »Details
A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome »Details
Long-term Efficacy and Safety Study With Oralgen Grass Pollen »Details
Efficacy and Safety of Grass Pollen Sublingual Immunotherapy »Details
International Guillain-Barré Syndrome Outcome Study »Details
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy »Details
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy »Details
A Study of Safety, Tolerability, and Evidence of Activity of FCFD4514S Administered Monthly or Every Other Month to Patients With Geographic Atrophy »Details
An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy »Details
A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder »Details
A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention »Details
N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders »Details
Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH) »Details
A Long-Term Safety Study of OZURDEX® in Clinical Practice »Details
Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy »Details
Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD) »Details
Natural History of the Progression of X-Linked Retinitis Pigmentosa »Details
Efficacy and Safety of BIIB111 for the Treatment of Choroideremia »Details
Natural History of the Progression of Choroideremia Study »Details
Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) »Details
A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) »Details
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema »Details
A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies »Details
Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma »Details
A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema »Details
Revacept in Symptomatic Carotid Stenosis »Details
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) »Details
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting »Details
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis »Details
Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren's Syndrome »Details
Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome »Details
Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS) »Details
European Disease Registry on Retinopathy of Prematurity (ROP) »Details
A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111 »Details
Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity »Details
High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV) »Details
Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients »Details
A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome »Details
Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa »Details
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome »Details
Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients »Details
A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome »Details
Clinical and Genetic Examination of Usher Syndrome Patients' Cohort in Europe »Details
Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion »Details
A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma »Details
Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT) »Details
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity »Details
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE) »Details
PRevention of Macular EDema After Cataract Surgery »Details
Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema »Details
Combination of Ranibizumab and Targeted Laser Photocoagulation »Details
Non-proliferative Diabetic Retinopathy Treated With Runcaciguat »Details
Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis »Details
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis »Details
SUBLIVAC FIX Phleum Pratense DT/DRF »Details
Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma »Details
PURETHAL Grasses Rush Study »Details
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema »Details
Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD »Details
A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) »Details
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma »Details
Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO »Details
Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis »Details
Rate of Progression in USH2A-related Retinal Degeneration »Details
Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy »Details
A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema »Details
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) »Details
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR) »Details
SUBLIVAC FIX Birch Phase III Short-term Efficacy »Details
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations »Details
PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis »Details
A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD) »Details
Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration »Details
A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU »Details
Twin SUBLIVAC® Grasses Clinical Efficacy Study »Details
Post Marketing Surveillance Study of Dysport »Details
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion »Details
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion »Details
A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR »Details
Reduction in the Occurrence of Center-Involved Diabetic Macular Edema »Details
Phase III Study in Refractory Behcet's Disease »Details
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria »Details
Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) »Details
Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema »Details
A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease »Details
SUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding »Details
A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD) »Details
AutoInflammatory Disease Alliance Registry (AIDA) »Details
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome »Details
Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder »Details
Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) »Details
A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome »Details
Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma »Details
Rainbow Extension Study »Details
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion »Details
Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) »Details
Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy »Details
Study of Retinal Oxygenation in Central Retinal Vein Occlusion »Details
A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease »Details
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) »Details
Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis »Details
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion »Details
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies »Details